S&P 500   4,250.20 (+0.49%)
DOW   33,084.75 (+0.25%)
QQQ   358.64 (+1.05%)
AAPL   172.91 (+0.30%)
MSFT   318.59 (+1.66%)
META   305.52 (+1.52%)
GOOGL   135.15 (+2.05%)
AMZN   126.19 (+1.18%)
TSLA   257.42 (+4.42%)
NVDA   439.41 (+0.97%)
NIO   8.75 (+1.63%)
BABA   84.17 (-0.44%)
AMD   102.28 (+2.20%)
T   14.53 (-1.69%)
F   12.06 (-0.08%)
MU   67.86 (+0.04%)
CGC   0.74 (+8.75%)
GE   108.82 (+0.98%)
DIS   79.27 (-0.34%)
AMC   8.03 (+2.29%)
PFE   33.61 (-0.86%)
PYPL   58.21 (+1.59%)
NFLX   378.60 (+0.49%)
S&P 500   4,250.20 (+0.49%)
DOW   33,084.75 (+0.25%)
QQQ   358.64 (+1.05%)
AAPL   172.91 (+0.30%)
MSFT   318.59 (+1.66%)
META   305.52 (+1.52%)
GOOGL   135.15 (+2.05%)
AMZN   126.19 (+1.18%)
TSLA   257.42 (+4.42%)
NVDA   439.41 (+0.97%)
NIO   8.75 (+1.63%)
BABA   84.17 (-0.44%)
AMD   102.28 (+2.20%)
T   14.53 (-1.69%)
F   12.06 (-0.08%)
MU   67.86 (+0.04%)
CGC   0.74 (+8.75%)
GE   108.82 (+0.98%)
DIS   79.27 (-0.34%)
AMC   8.03 (+2.29%)
PFE   33.61 (-0.86%)
PYPL   58.21 (+1.59%)
NFLX   378.60 (+0.49%)
S&P 500   4,250.20 (+0.49%)
DOW   33,084.75 (+0.25%)
QQQ   358.64 (+1.05%)
AAPL   172.91 (+0.30%)
MSFT   318.59 (+1.66%)
META   305.52 (+1.52%)
GOOGL   135.15 (+2.05%)
AMZN   126.19 (+1.18%)
TSLA   257.42 (+4.42%)
NVDA   439.41 (+0.97%)
NIO   8.75 (+1.63%)
BABA   84.17 (-0.44%)
AMD   102.28 (+2.20%)
T   14.53 (-1.69%)
F   12.06 (-0.08%)
MU   67.86 (+0.04%)
CGC   0.74 (+8.75%)
GE   108.82 (+0.98%)
DIS   79.27 (-0.34%)
AMC   8.03 (+2.29%)
PFE   33.61 (-0.86%)
PYPL   58.21 (+1.59%)
NFLX   378.60 (+0.49%)
S&P 500   4,250.20 (+0.49%)
DOW   33,084.75 (+0.25%)
QQQ   358.64 (+1.05%)
AAPL   172.91 (+0.30%)
MSFT   318.59 (+1.66%)
META   305.52 (+1.52%)
GOOGL   135.15 (+2.05%)
AMZN   126.19 (+1.18%)
TSLA   257.42 (+4.42%)
NVDA   439.41 (+0.97%)
NIO   8.75 (+1.63%)
BABA   84.17 (-0.44%)
AMD   102.28 (+2.20%)
T   14.53 (-1.69%)
F   12.06 (-0.08%)
MU   67.86 (+0.04%)
CGC   0.74 (+8.75%)
GE   108.82 (+0.98%)
DIS   79.27 (-0.34%)
AMC   8.03 (+2.29%)
PFE   33.61 (-0.86%)
PYPL   58.21 (+1.59%)
NFLX   378.60 (+0.49%)
LON:INDV

Indivior (INDV) Share Forecast, Price & News

GBX 1,626
-36.00 (-2.17%)
(As of 04:45 PM ET)
Compare
Today's Range
1,621
1,681
50-Day Range
1,662
1,885
52-Week Range
1,330
2,020
Volume
228,021 shs
Average Volume
391,503 shs
Market Capitalization
£2.24 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
GBX 2,460

INDV stock logo

About Indivior (LON:INDV) Stock

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet. The company operates in approximately 40 countries worldwide. It has collaboration agreement with Addex Therapeutics Ltd. The company was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.

INDV Price History

INDV Stock News Headlines

Indivior PLC (INDV): Unveiling Its Market Value
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Indivior to Commence Trading on Nasdaq
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
INDV.L - Indivior PLC
Indivior Announces Q1 2023 Financial Results
FY 2022 Financial Results Announced
Indivior To Acquire Opiant Pharmaceuticals
See More Headlines
Receive INDV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Indivior and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Drug Manufacturers—Specialty & Generic
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
1,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
GBX 2,460
High Stock Price Forecast
GBX 2,700
Low Stock Price Forecast
GBX 2,330
Forecasted Upside/Downside
+48.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
£-59,000,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£1 billion
Cash Flow
GBX 620.13 per share
Book Value
GBX 85 per share

Miscellaneous

Free Float
N/A
Market Cap
£2.29 billion
Optionable
Not Optionable
Beta
N/A
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Mr. Mark Crossley
    CEO & Exec. Director
  • Mr. Ryan Preblick
    CFO & Exec. Director
  • Dr. Christian Heidbreder
    Chief Scientific Officer
  • Mr. Jason Thompson
    VP of Investor Relations
  • Ms. Cynthia Cetani
    Chief Integrity & Compliance Officer
  • Mr. Jeffrey W. Burris (Age 51)
    Chief Legal Officer
  • Mr. Jon Fogle
    Chief HR Officer
  • Mr. Richard Simkin
    Chief Commercial Officer
  • Mr. Hillel West
    Chief Manufacturing & Supply Officer
  • Ms. Nina DeLorenzo
    Chief Global Impact Officer













INDV Stock - Frequently Asked Questions

Should I buy or sell Indivior stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Indivior in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" INDV shares.
View INDV analyst ratings
or view top-rated stocks.

What is Indivior's stock price forecast for 2023?

2 Wall Street analysts have issued twelve-month price targets for Indivior's shares. Their INDV share price forecasts range from GBX 2,330 to GBX 2,700. On average, they predict the company's stock price to reach GBX 2,460 in the next year. This suggests a possible upside of 48.0% from the stock's current price.
View analysts price targets for INDV
or view top-rated stocks among Wall Street analysts.

How have INDV shares performed in 2023?

Indivior's stock was trading at GBX 1,852 at the start of the year. Since then, INDV shares have decreased by 10.3% and is now trading at GBX 1,662.
View the best growth stocks for 2023 here
.

What other stocks do shareholders of Indivior own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Indivior investors own include Bigblu Broadband (BBB), Futura Medical (FUM), Directa Plus (DCTA), Lakehouse (LAKE), Aquila Services Group (AQSG), Benchmark (BMK), Bodycote (BOY), CityFibre Infrastructure (CITY), Deltex Medical Group (DEMG) and Kingfisher (KGF).

What is Indivior's stock symbol?

Indivior trades on the London Stock Exchange (LON) under the ticker symbol "INDV."

How do I buy shares of Indivior?

Shares of INDV stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Indivior's stock price today?

One share of INDV stock can currently be purchased for approximately GBX 1,662.

How much money does Indivior make?

Indivior (LON:INDV) has a market capitalization of £2.29 billion and generates £1 billion in revenue each year. The specialty pharmaceutical company earns £-59,000,000.00 in net income (profit) each year or GBX (0.33) on an earnings per share basis.

How many employees does Indivior have?

The company employs 1,000 workers across the globe.

How can I contact Indivior?

Indivior's mailing address is 103-105 Bath Road, SLOUGH, SL1 3UH, United Kingdom. The official website for the company is indivior.com. The specialty pharmaceutical company can be reached via phone at +44-1753-217800.

This page (LON:INDV) was last updated on 10/4/2023 by MarketBeat.com Staff

My Account -